Wall Street
Price Targets

OPA Price Targets Summary
Orpea SA

There are no price targets for OPA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Orpea SA Competitors:
Price Targets
JYNT
Joint Corp
24% Upside
A50
Thomson Medical Group Ltd
9% Upside
300015
Aier Eye Hospital Group Co Ltd
33% Upside
SILO
Siloam International Hospitals Tbk PT
11% Upside
4009
Middle East Healthcare Company SJSC
9% Upside
VIH
Srivichai vejvivat PCL
70% Upside
BMHS
Bundamedik Tbk PT
17% Upside

Revenue
Forecast

Revenue Estimate
Orpea SA

For the last 8 years the compound annual growth rate for Orpea SA's revenue is 10%. The projected CAGR for the next 3 years is 7%.

10%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Orpea SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Orpea SA

For the last 8 years the compound annual growth rate for Orpea SA's net income is 34%. The projected CAGR for the next 3 years is -68%.

34%
Past Growth
-68%
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPA's stock price target?
Not Available

OPA doesn't have any price targets made by Wall Street professionals.

What is Orpea SA's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Orpea SA's revenue is 10%. The projected CAGR for the next 3 years is 7%.

What is Orpea SA's Net Income forecast?
Projected CAGR
-68%

For the last 8 years the compound annual growth rate for Orpea SA's net income is 34%. The projected CAGR for the next 3 years is -68%.

Back to Top